United States· US:71872-7318_15eaa42c-d1e7-5c08-e063-6394a90ae469
Cortrosyn
A medicinal product containing cosyntropin, registered in United States by Medical Purchasing Solutions, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- COSYNTROPIN
- Manufacturer
- Medical Purchasing Solutions, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1171872731811 VIAL in 1 BAG (71872-7318-1) / 1 mL in 1 VIAL
- ndc1171872-7318-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cosyntropin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomSynacthen 250micrograms/1ml solution for injection ampoulesAtnahs Pharma UK Ltd
- CanadaCORTROSYN INJ 0.25MGAMPHASTAR PHARMACEUTICALS, INC.
- NorwaySynacthenAlfasigma S.p.A
- SpainNUVACTHEN DEPOT 1MG/ML SUSPENSIÓN INYECTABLEAlfasigma S.P.A.
- Japanテトラコサクチド酢酸塩アルフレッサファーマ
- NetherlandsSynacthen 0,25 mg/ml, oplossing voor injectie of infusieAlfasigma S.p.A.
- SwitzerlandSynacthen, InjektionslösungAtnahs Pharma Switzerland AG
- SwedenSynacthen 0,25 mg/ml Injektions-/infusionsvätska, lösningAlfasigma S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Synacthen Ampulle, Synacthen Depot
- Belgium · Synacthen, Synacthen Depot
- Denmark · Synacthen
- France · Synacthene, Synacthene Retard
- Ireland · Synacthen
- Italy · Synacthen
- Luxembourg · Synacthen, Synacthen Dépôt
- Netherlands · Synacthen
- Sweden · Synacthen, Synacthen Depot
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cca5f3e1-4c62-4ee0-9e55-8e5830725b66 GET /v1/drugs/cca5f3e1-4c62-4ee0-9e55-8e5830725b66?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": ".25",
"substance": "COSYNTROPIN",
"productndc": "71872-7318",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA016750",
"marketing_category": "NDA"
}See everything about cosyntropin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.